TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
-9.4%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.21B
AUM Growth
-$432M
(-16%)
Cap. Flow
-$82.9M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
42.68%
Holding
227
New
13
Increased
52
Reduced
76
Closed
10
Top Buys
| 1 |
Biogen
BIIB
|
$15.1M |
| 2 |
Centene
CNC
|
$8.24M |
| 3 |
Moderna
MRNA
|
$7.61M |
| 4 |
Eli Lilly
LLY
|
$6.73M |
| 5 |
Sanofi
SNY
|
$6.15M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$14.8M |
| 2 |
Merck
MRK
|
$14.5M |
| 3 |
MDCO
Medicines Co
MDCO
|
$10.3M |
| 4 |
Johnson & Johnson
JNJ
|
$10.2M |
| 5 |
Pfizer
PFE
|
$8.65M |
Sector Composition
| 1 | Healthcare | 95.66% |
| 2 | Real Estate | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTC
76
LTC Properties
LTC
$1.69B
| $5.63M | 0.25% |
182,293
+16,625
| +10% | +$514K |
|
|
BMY.RT
77
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $5.6M | 0.25% |
1,473,710
| – | – |
|
78
Ventas
VTR
$30.9B
| $5.58M | 0.25% |
208,108
+16,720
| +9% | +$448K |
|
79
Sabra Healthcare REIT
SBRA
$4.56B
| $5.58M | 0.25% |
510,660
+44,413
| +10% | +$485K |
|
80
PTC Therapeutics
PTCT
$4.55B
| $5.39M | 0.24% |
120,827
+21,500
| +22% | +$959K |
|
|
ZGNX
81
DELISTED
Zogenix, Inc.
ZGNX
| $5.33M | 0.24% |
215,406
+107,703
| +100% | +$2.66M |
|
82
Theravance Biopharma
TBPH
$703M
| $5.29M | 0.24% |
228,836
+111,111
| +94% | +$2.57M |
|
|
CERN
83
DELISTED
Cerner Corp
CERN
| $5.13M | 0.23% |
+81,500
| New | +$5.13M |
|
|
RETA
84
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.07M | 0.23% |
35,129
+8,717
| +33% | +$1.26M |
|
85
Teleflex
TFX
$5.78B
| $5.05M | 0.23% |
17,252
+1,644
| +11% | +$481K |
|
86
Cencora
COR
$56.7B
| $4.79M | 0.22% |
54,107
-61,616
| -53% | -$5.45M |
|
87
Allogene Therapeutics
ALLO
$255M
| $4.75M | 0.21% |
244,261
+163,981
| +204% | +$3.19M |
|
88
Waters Corp
WAT
$18.2B
| $4.73M | 0.21% |
+26,000
| New | +$4.73M |
|
89
Nektar Therapeutics
NKTR
$764M
| $4.7M | 0.21% |
17,539
-1,373
| -7% | -$368K |
|
90
Apellis Pharmaceuticals
APLS
$3.55B
| $4.65M | 0.21% |
173,494
+42,495
| +32% | +$1.14M |
|
|
AVDL
91
Avadel Pharmaceuticals
AVDL
$1.53B
| $4.5M | 0.2% |
566,066
-248,522
| -31% | -$1.97M |
|
92
Dentsply Sirona
XRAY
$2.92B
| $4.46M | 0.2% |
114,736
-5,000
| -4% | -$194K |
|
93
Xencor
XNCR
$610M
| $4.43M | 0.2% |
148,231
| – | – |
|
|
GWPH
94
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.39M | 0.2% |
50,101
| – | – |
|
95
Ultragenyx Pharmaceutical
RARE
$3.07B
| $4.33M | 0.2% |
97,480
| – | – |
|
|
ABMD
96
DELISTED
Abiomed Inc
ABMD
| $4.29M | 0.19% |
29,516
-3,200
| -10% | -$465K |
|
|
SYNH
97
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.26M | 0.19% |
108,001
-7,841
| -7% | -$309K |
|
98
Mettler-Toledo International
MTD
$26.9B
| $4.23M | 0.19% |
6,123
+1,900
| +45% | +$1.31M |
|
99
Labcorp
LH
$23.2B
| $3.97M | 0.18% |
36,578
| – | – |
|
|
GRTX
100
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $3.96M | 0.18% |
416,666
| – | – |
|